Accessibility Menu
Lonza Group Ag logo

Lonza Group Ag(OTC) LZAGF

Market Cap$51.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+1,460%
5 Year-9%
1 Year+4%
1 Month+6%
$704.82
-4.26%
-31.38Today
Lonza Group Ag last closing stock price
MetricPriceDate
Last closeUSD 736.202026-09-03
Lonza Group Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.27%USD 734.212026-08-27
1 month+6.34%USD 692.302026-08-04
3 month+16.2%USD 633.542026-06-05
Year to date+9.33%USD 673.402025-12-31
1 year+4.47%USD 704.732025-09-03
3 year+31.78%USD 558.662023-09-01
5 year-9.49%USD 813.432021-09-03
Since inception+1,460.47%USD 47.182003-07-08

Lonza Group Ag Financials at a Glance

Market Cap

$51.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 13.40B

Net Income (TTM)

CHF 1.80B

EPS (TTM)

-$1.77

P/E Ratio

-420.49

Dividend

$3.19

Beta (Volatility)

0.65 (Low)

Price

$704.82

Volume

300

Open

$719.50

Previous Close

$704.82

Daily Range

$686.60 - $719.50

52-Week Range

$565.14 - $755.96

Estimated Earnings Date

Jul 22, 2026

LZAGF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lonza Group Ag

Lonza Group AG, established in 1897 and headquartered in Basel, Switzerland, is a leading global provider of critical products and services for the pharmaceutical, biotechnology, and nutrition sectors. The company operates across multiple continents, delivering innovative solutions through its four primary divisions.

Products and Services
  • Biologics: Contract development and manufacturing of biopharmaceuticals
  • Small Molecules: Development and manufacturing of small molecule active pharmaceutical ingredients
  • Cell & Gene: Technologies for manufacturing cell and gene therapies
Growth Outlook
  • Revenue of CHF 3.36 billion in Q2 2026, reflecting strong demand
  • Operating income margin improved to 23.9% in Q2 2026
  • Focus on expanding capabilities in cell and gene therapy markets
Financial Highlights
  • Net income of CHF 587.7 million in Q2 2026, up from CHF 483.2 million in Q4 2025
  • Gross profit margin increased to 38.4% in Q2 2026
  • Dividend yield of 0.86% based on trailing twelve months data
Lonza Group AG has established itself as a key player in the biotechnology industry, with a diverse portfolio that caters to various market needs. The company's recent financial performance indicates a robust growth trajectory, particularly in the biologics and cell & gene therapy sectors. The increase in revenue and net income highlights the effectiveness of its operational strategies and market positioning. With a focus on innovation and expansion, Lonza is well-positioned to capitalize on emerging opportunities in the healthcare sector.
AI Generated • Aug 29, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

16,866

CEO

Wolfgang Wienand, PhD

Website

www.lonza.com

Headquarters

Basel, BS 4002, CH

LZAGF Financials

Key Financial Metrics (TTM)

Gross Margin

36.53%

Operating Margin

24.57%

Net Income Margin

-1.74%

Return on Equity

-1.28%

Return on Capital

9.06%

Return on Assets

-0.60%

Earnings Yield

-0.24%

Dividend Yield

0.43%

Payout Ratio

-3.39%

Stock Overview

Market Cap

$51.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

69.84M

Volume

300

Avg. Volume

305.625

Financials (TTM)

Gross Profit

CHF 4.59B

Operating Income

CHF 2.50B

EBITDA

CHF 3.66B

Operating Cash Flow

CHF 2.59B

Capital Expenditure

-CHF 2.74B

Free Cash Flow

-CHF 157.42M

Cash & ST Invst.

CHF 487.00M

Total Debt

CHF 4.17B

Lonza Group Ag Performance Analysis

Lonza Group Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF 6,515,786,09010.1%
20232023-12-31CHF 7,474,530,58714.7%
20242024-12-31CHF 6,222,552,302-16.7%
20252025-12-31CHF 7,864,067,67926.4%
Lonza Group Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3115.0%
Q22025-06-301.7%
Q42025-12-31-17.3%
Q22026-06-3013.5%
Lonza Group Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF 17.11-60.4%
20232023-12-31CHF 9.88-42.3%
20242024-12-31CHF 10.132.6%
20252025-12-31CHF -4.73N/A
Lonza Group Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-6.5%
Q22025-06-3040.8%
Q42025-12-31-264.7%
Q22026-06-30184.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CHF 3.36B

+9.7%

Gross Profit

CHF 1.29B

+15.4%

Gross Margin

38.38%

N/A

Market Cap

$51.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.86M

N/A

Employees

17,995

N/A

Net Income

CHF 587.68M

+78.6%

EBITDA

CHF 1.14B

+34.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CHF 487.00M

-75.9%

Total Debt

CHF 4.17B

+9.8%

Accounts Receivable

CHF 1.92B

+23.8%

Inventory

CHF 1.88B

+9.7%

Long Term Debt

CHF 3.39B

-6.8%

Short Term Debt

CHF 774.00M

+399.4%

Return on Assets

-0.60%

N/A

Return on Invested Capital

11.04%

N/A

Free Cash Flow

CHF 80.54M

+168.8%

Operating Cash Flow

CHF 656.29M

+30.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UCBJFUCB S.A.
$255.34+2.71%
HOCPFHOYA Corporation
$163.76+9.72%
UCBJYUCB S.A.
$122.38-4.82%
HLNCFHaleon plc
$4.74-3.97%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About LZAGF

What is the current price of Lonza Group Ag?

Lonza Group Ag is trading at $704.82 per share.

What is the 52-week range for Lonza Group Ag?

Over the past 52 weeks, Lonza Group Ag has traded between $565.14 and $755.96.

How much debt does Lonza Group Ag have?

As of the most recent reporting period, Lonza Group Ag reported total debt of CHF 5.73B.

How much cash does Lonza Group Ag have on hand?

Lonza Group Ag reported CHF 907.54M in cash and cash equivalents in its most recent financial results.

What is Lonza Group Ag’s dividend yield?

Lonza Group Ag currently has a dividend yield of 0.43%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services